Optimising PrEP uptake and use in Peru: no time to lose!

Lancet HIV. 2024 Apr;11(4):e204-e206. doi: 10.1016/S2352-3018(24)00038-9.
No abstract available

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Homosexuality, Male
  • Humans
  • Male
  • Peru / epidemiology
  • Pre-Exposure Prophylaxis*

Substances

  • Anti-HIV Agents